Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
NINGBO INNO PHARMCHEM CO.,LTD. is committed to fueling innovation in cancer treatment by supplying high-quality Active Pharmaceutical Ingredients (APIs) like Cabozantinib S-Malate (CAS 1140909-48-3). This compound represents a significant advancement in targeted therapy, serving as a critical antineoplastic agent that offers new hope for patients battling various forms of cancer.
The innovation in cancer therapy often stems from a deeper understanding of the molecular mechanisms driving disease progression. Cabozantinib S-Malate, as a potent small molecule multi-tyrosine kinase inhibitor, targets key signaling pathways that are aberrant in cancer cells. Specifically, its action as a MET and VEGFR2 inhibitor disrupts processes vital for tumor growth, survival, and vascularization. This targeted approach is revolutionizing how we approach cancer treatment, moving towards more personalized and effective strategies.
The development of Cabozantinib S-Malate as a leading treatment for advanced renal cell carcinoma and as a medullary thyroid cancer drug exemplifies successful innovation in oncology. Pharmaceutical companies rely on the consistent quality and availability of such APIs to bring novel cancer therapies to market. NINGBO INNO PHARMCHEM CO.,LTD. plays a crucial role in this ecosystem by ensuring a stable supply of this high-purity pharmaceutical chemical, supporting research and production efforts.
The ongoing research into new applications for tyrosine kinase inhibitors like Cabozantinib S-Malate continues to drive innovation in the field. By understanding and leveraging the specific inhibitory actions of this compound, scientists and clinicians are exploring its potential against a wider range of cancers. Our commitment to providing this vital ingredient enables these critical advancements in cancer therapy development.
For organizations involved in the pioneering of new cancer treatments, NINGBO INNO PHARMCHEM CO.,LTD. offers Cabozantinib S-Malate as a cornerstone ingredient. Partner with us to accelerate your development of groundbreaking cancer therapies and contribute to a future where targeted treatments offer improved outcomes for patients worldwide.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
